Eugene Braunwald

Eugene Braunwald

Auto-generated profile, based on publicly available information

Eugene Braunwald

Harvard Medical School , Boston , Massachusetts

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
EBEugene Braunwald
Eugene Braunwald
Heart failure results not only from cardiac overload or injury but also from a complex interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on cardiac myocytes, the cardiac interstitium, or both. This review focuses on biomarkers for heart failure other than routinely determined laboratory values and discusses how these might be used in assessing and managing heart failure.

1 February 2013 in JACC: Heart Failure
Verified
Journal Article
Closed access
EBEugene Braunwald
Eugene Braunwald

1 February 2015 in The Lancet
Verified
Journal Article
Closed access
EBEugene Braunwald
Eugene Braunwald

1 February 2020 in JACC
Verified
Journal Article
Closed access
TZThomas A. Zelniker
Thomas A. Zelniker
EBEugene Braunwald
Eugene Braunwald

26 May 2022 in New England Journal of Medicine
Verified
Journal Article
Closed access
EBEugene Braunwald
Eugene Braunwald
Gliflozins — sodium–glucose cotransporter 2 inhibitors — lower blood glucose and glycated hemoglobin in patients with type 2 diabetes without causing hypoglycemia. The agents also improve cardiac function in patients who have heart failure with or without type 2 diabetes and improve renal function, with few adverse effects.

1 July 2019 in Progress in Cardiovascular Diseases
Verified
Journal Article
Closed access
EBEugene Braunwald
Eugene Braunwald